Analyst Consensus
- Current Price
- 73.07 $
- Target (Low)
- 58.00 $
- Target (Mean)
- 90.40 $
- Target (High)
- 119.16 $
- Recommendation
- Buy
- Number of Analysts
- 40
Recommendation Distribution
Recommendation Distribution| Strong Buy | 8 |
|---|
| Buy | 28 |
|---|
| Hold | 7 |
|---|
| Sell | 0 |
|---|
| Strong Sell | 1 |
|---|
Key Ratios
- Net Profit Margin
- 3.3%
- Operating Margin
- -2.6%
- Gross Margin
- 45.1%
- Return on Equity (ROE)
- 3.7%
- Return on Assets (ROA)
- 2.1%
- Revenue Growth
- 4.9%
- Debt/Equity
- 37.51
- Current Ratio
- 1.99
- Beta
- 2.55
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| May 29, 2026 | Morgan Stanley | Overweight → Overweight |
| May 27, 2026 | Truist Securities | Buy → Buy |
| May 18, 2026 | Canaccord Genuity | Buy → Buy |
| May 12, 2026 | Macquarie | Neutral → Neutral |
| May 8, 2026 | Citigroup | Buy → Buy |
| May 8, 2026 | RBC Capital | Outperform → Outperform |